The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
Experimental and clinical studies have shown that aldosterone/mineralocorticoid receptor (MR) activation has deleterious effects in the cardiovascular system; however, the signalling pathways involved in the pathophysiological effects of aldosterone/MR in vivo are not fully understood. Several in vi...
Saved in:
Main Authors: | Smail Messaoudi, An Di Zhang, Violaine Griol-Charhbili, Brigitte Escoubet, Junichi Sadoshima, Nicolette Farman, Frederic Jaisser |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/b89b461687e94da88897642bde4e2bc2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.
by: Aurelie Nguyen Dinh Cat, et al.
Published: (2012) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
by: Ewa Szczepanska-Sadowska, et al.
Published: (2021) -
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
by: Miklós Fagyas, et al.
Published: (2014) -
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
by: Susanne Rysz, et al.
Published: (2021)